Jun 19, 2023 / 12:00PM GMT
David A. Walsey - MEI Pharma, Inc. - SVP of Corporate Affairs
Hello, and thank you for joining the MEI Pharma and Infinity Pharmaceuticals merger and clinical program overview webcast. My name is David Walsey, and I'm the Senior Vice President of Corporate Affairs at MEI Pharma. Presenting today to tell you about the potential of the pending merger are from MEI, David Urso, President and CEO; and Dr. Richard Ghalie, Chief Medical Officer. From Infinity, we are joined by Dr. Robert Ilaria, Chief Medical Officer. Subject to the approval and closing of the pending merger of the 2 companies, David and Robert will be the CEO and CMO of the combined entity, respectively. Also joining today is Dr. Ezra Cohen, a leading medical oncologist and cancer researcher recently the Chief of the Division of Hematology Oncology and Associate Director of Clinical Science at UC San Diego Moores Cancer Center.
Joining for a Q&A discussion will be Dr. Nick Abbott. Nick brings over 35 years of biotech experience including research as a bench scientist at both U.K. and U.S. companies and from Wall Street, where he was
Infinity Pharmaceuticals Inc and MEI Pharma Inc Merger Agreement Call - Pre-recorded Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers